Functionally, wound-healing and transwell assays showed that overexpression of CEBPA-DT could enhance the motility of hepatoma cells, while deletion of DDR2 could block this enhancement (Figure S6A-D). This evidence concerns the gene CEBPA and hepatocellular carcinoma.